Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Ovarian Neoplasms × Whole Genome Sequencing × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1 Neoplasms, Unknown Primary 1

Interventions

Paclitaxel 280 Carboplatin 280 Bevacizumab 147 pembrolizumab 93 Gemcitabine 86 liposomal doxorubicin 85 Cyclophosphamide 82 Cisplatin 77 olaparib 76 Topotecan 76 niraparib 53 Docetaxel 48 Doxorubicin 45 Taxes 39 Drug Therapy 38 fludarabine 36 Nivolumab 34 Filgrastim 31 Specimen Handling 28 Etoposide 28 Magnetic Resonance Spectroscopy 25 Peripheral Blood Stem Cell Transplantation 23 durvalumab 22 Immunoglobulin G 22 Disulfides 22 Hyperthermic Intraperitoneal Chemotherapy 21 aldesleukin 20 Albumin-Bound Paclitaxel 20 atezolizumab 19 Oxaliplatin 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04846933 2025-01-16

DECIDER

Turku University Hospital

Phase NA Recruiting

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡